Active, Not Recruiting
Phase 3 Evaluation of Efficacy and Safety of AR882 in Gout Patients (AR882-301)
NCT06846515
- Conditions
- Arthritis, Arthritis, Gouty, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +14 more
- Locations
-
- Arthrosi Investigative Site (620) Birmingham, Alabama, United States
- Arthrosi Investigative Site (616) Huntsville, Alabama, United States
- Arthrosi Investigative Site (680) Peoria, Arizona, United States
- Arthrosi Investigative Site (640) Phoenix, Arizona, United States